Feasibility of laboratory monitoring in community pharmacy by point of care testing of creatinine and potassium in ambulatory elderly at risk for impaired renal functio

Completed

• Conditions: Impaired renal function; Chronic Kidney Disease; 10038430

• Registration Number: NL-OMON34595
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

Eldery 70 years old or older, under treatment by their own GP. Users on maintenance therapy for diabetis and/or cardiovascular diseases for which therapy adjustments are necessary in case of impaired renal function
ambulatory

Exclusion Criteria

MDRD =< 10 ml/min

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p> Feasibility of laboratory monitoring in community pharmacies by Point-Of-Care<br /><br>testing creatinine and potassium in ambulatory elderly at risk for impaired<br /><br>renal function. Evaluation of experiences of the patients, pharmacy employees<br /><br>and GPs by a questionnaire.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1. Number of approved pharmacist advices by the total number of pharmacist<br /><br>advices after POC-testing<br /><br>2. Number of subjects with POC-testing by total number of included subjects<br /><br>3. Number of subjects with impaired renal function (< 50 ml/min/1.73 m2) by the<br /><br>total number of included subjects<br /><br>4. Number of subjects with abnormal potassium levels by the total number of<br /><br>included subjects. Hyperkalemia: > 6.0 mmol/l; normal: 3.5 - 5.0 mmol/l;<br /><br>hypokalemia: < 3.0 mmol/l.<br /><br>5. Number of subjects exposed to a second POC-test by number of subjects with<br /><br>POC-testing</p><br>